Gelo dela Cruz is the manager of the Flow Cytometry Platform at the Novo Nordisk Foundation Center for Stem Cell Medicine – reNEW and the NNF Center for Protein Research. Educated and trained in molecular biology in the Philippines and the United States, he started his flow cytometry career as an operator at the New York University Cancer Institute Flow Cytometry core facility in 2006.
In 2010, he moved to Heidelberg to work at the flow cytometry core facility of the German Cancer Research Center. He was then recruited in 2012 to establish and start up the core facility at the Danish Stem Cell Center in Copenhagen. He is a 2015 International Society for the Advancement of Cytometry (ISAC) Shared Resource Laboratory Emerging Leader and currently a member of the ISAC Council.